Functional Impact of Allosteric Agonist Activity of Selective Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 in Regulating Central Nervous System Function

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Pharmacology

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/mol.111.075184PMID 22021324PMCID PMC3263948
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabotropic glutamate receptors as therapeutic targets for schizophrenia.

  2012cited by this paper
• Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.

  2011cited by this paper
• Discovery of novel positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5).

  2011cited by this paper
• Synthesis and SAR of centrally active mGlu5 positive allosteric modulators based on an aryl acetylenic bicyclic lactam scaffold.

  2011influential reference
• Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity

  2010influential reference
• Metabotropic glutamate receptors: physiology, pharmacology, and disease.

  2010cited by this paper
• Chemical switch of a metabotropic glutamate receptor 2 silent allosteric modulator into dual metabotropic glutamate receptor 2/3 negative/positive allosteric modulators.

  2010cited by this paper
• Glutamatergic (N-Methyl-d-aspartate Receptor) Hypofrontality in Schizophrenia: Too Little Juice or a Miswired Brain?

  2010cited by this paper
• mGluR5 positive allosteric modulators facilitate both hippocampal LTP and LTD and enhance spatial learning

  2009influential reference
• Discovery of molecular switches that modulate modes of metabotropic glutamate receptor subtype 5 (mGlu5) pharmacology in vitro and in vivo within a series of functionalized, regioisomeric 2- and 5-(phenylethynyl)pyrimidines.

  2009cited by this paper
• Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders

  2009cited by this paper
• Effects of a metabotropic glutamate receptor group II agonist LY354740 in animal models of positive schizophrenia symptoms and cognition

  2009cited by this paper
• A Novel Assay of Gi/o-Linked G Protein-Coupled Receptor Coupling to Potassium Channels Provides New Insights into the Pharmacology of the Group III Metabotropic Glutamate Receptors

  2008cited by this paper
• Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia.

  2008cited by this paper
• N-{4-Chloro-2-[(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)methyl]phenyl}-2-hydroxybenzamide (CPPHA) Acts through a Novel Site as a Positive Allosteric Modulator of Group 1 Metabotropic Glutamate Receptors

  2008cited by this paper
• ADX47273 [S-(4-Fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: A Novel Metabotropic Glutamate Receptor 5-Selective Positive Allosteric Modulator with Preclinical Antipsychotic-Like and Procognitive Activities

  2008cited by this paper
• Brain-Derived Neurotrophic Factor Rescues Synaptic Plasticity in a Mouse Model of Fragile X Syndrome

  2007cited by this paper
• High-throughput screening of drug-brain tissue binding and in silico prediction for assessment of central nervous system drug delivery.

  2007cited by this paper
• Interaction of Novel Positive Allosteric Modulators of Metabotropic Glutamate Receptor 5 with the Negative Allosteric Antagonist Site Is Required for Potentiation of Receptor Responses

  2007cited by this paper
• Sustained activation of metabotropic glutamate receptor 5 and protein tyrosine phosphatases mediate the expression of (S)‐3,5‐dihydroxyphenylglycine‐induced long‐term depression in the hippocampal CA1 region

  2006cited by this paper
• A Close Structural Analog of 2-Methyl-6-(phenylethynyl)-pyridine Acts as a Neutral Allosteric Site Ligand on Metabotropic Glutamate Receptor Subtype 5 and Blocks the Effects of Multiple Allosteric Modulators

  2005cited by this paper
• Allosteric Potentiators of Metabotropic Glutamate Receptor Subtype 5 Have Differential Effects on Different Signaling Pathways in Cortical Astrocytes

  2005cited by this paper
• A Novel Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Has in Vivo Activity and Antipsychotic-Like Effects in Rat Behavioral Models

  2005cited by this paper
• The mGluR theory of fragile X mental retardation.

  2004cited by this paper
• A Novel Selective Allosteric Modulator Potentiates the Activity of Native Metabotropic Glutamate Receptor Subtype 5 in Rat Forebrain

  2004influential reference
• LTP and LTD: an embarrassment of riches.

  2004cited by this paper
• Modulation of Presynaptic Calcium Transients by Metabotropic Glutamate Receptor Activation: A Differential Role in Acute Depression of Synaptic Transmission and Long-Term Depression

  2002cited by this paper
• Altered synaptic plasticity in a mouse model of fragile X mental retardation

  2002cited by this paper
• Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1.

  2001cited by this paper
• Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons.

  2001cited by this paper
• Metabotropic Glutamate Receptors 1 and 5 Differentially Regulate CA1 Pyramidal Cell Function

  2001cited by this paper
• A novel, competitive mGlu5 receptor antagonist (LY344545) blocks DHPG‐induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices

  2000cited by this paper
• Activation of Metabotropic Glutamate Receptor 5 Has Direct Excitatory Effects and Potentiates NMDA Receptor Currents in Neurons of the Subthalamic Nucleus

  2000cited by this paper
• A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices.

  2000cited by this paper
• Phosphorylation of Mitogen‐Activated Protein Kinase in Cultured Rat Cortical Glia by Stimulation of Metabotropic Glutamate Receptors

  1998cited by this paper
• Priming of long‐term potentiation induced by activation of metabotropic glutamate receptors coupled to phospholipase C

  1998cited by this paper
• Mice Lacking Metabotropic Glutamate Receptor 5 Show Impaired Learning and Reduced CA1 Long-Term Potentiation (LTP) But Normal CA3 LTP

  1997cited by this paper
• Expression of group one metabotropic glutamate receptor subunit mRNAs in neurochemically identified neurons in the rat neostriatum, neocortex, and hippocampus.

  1997cited by this paper
• Pharmacology and functions of metabotropic glutamate receptors.

  1997cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Differential expression of mGluR5 metabotropic glutamate receptor mRNA by rat striatal neurons

  1995cited by this paper
• Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.

  1994cited by this paper
• Blockade of glutamate excitotoxicity and its clinical applications

  1993cited by this paper
• An Embarrassment of Riches

  1992cited by this paper
• Ketamine: behavioral effects of subanesthetic doses.

  1984cited by this paper

• Functional dynamics of G protein-coupled receptors reveal new routes for drug discovery

  2025cites this paper
• Pharmacological characterisation of allosteric modulators at human mGlu5.

  2025cites this paper
• Spontaneous glutamate release activates mGluR signaling to drive rapid antidepressant responses

  2025influential citation
• Conformational diversity in class C GPCR positive allosteric modulation

  2025cites this paper
• Metabotropic glutamate receptors in GtoPdb v.2025.3

  2025cites this paper
• Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition

  2024cites this paper
• Binding sites and design strategies for small molecule GLP-1R agonists.

  2024cites this paper
• Mechanisms of Action Underlying Conductance-Modifying Positive Allosteric Modulators of the NMDA Receptor

  2024cites this paper
• Group I mGluRs positive allosteric modulators improved schizophrenia-related behavioral and molecular deficits in the Poly I:C rat model.

  2023cites this paper
• Rigorous Characterization of Allosteric Modulation of the Human Metabotropic Glutamate Receptor 1 Reveals Probe- and Assay-Dependent Pharmacology

  2023cites this paper
• Metabotropic glutamate receptors in GtoPdb v.2023.1

  2023cites this paper
• Metabotropic Glutamate Receptors As Emerging Targets for the Treatment of Schizophrenia

  2022cites this paper
• Opportunities and challenges for the development of M1 muscarinic receptor positive allosteric modulators in the treatment for neurocognitive deficits

  2022cites this paper
• Spinophilin limits metabotropic glutamate receptor 5 scaffolding to the postsynaptic density and cell type-specifically mediates excessive grooming

  2022cites this paper
• Recent Developments in Treating Cognitive Impairment Associated with Schizophrenia

  2021cites this paper
• Metabotropic glutamate receptors in GtoPdb v.2021.3

  2021cites this paper
• Therapeutic Targeting of a7 Nicotinic Acetylcholine Receptors

  2021cites this paper
• Positive Allosteric Modulators of Metabotropic Glutamate Receptor 5 as Tool Compounds to Study Signaling Bias

  2021cites this paper
• Pharmacological Target Engagement and Validation

  2021cites this paper
• Selective Photoswitchable Allosteric Agonist of a G Protein-Coupled Receptor

  2021cites this paper
• Classic and Modern Approaches to Investigating Interactions Between Dopamine Systems and Metabotropic Glutamate Receptors

  2021cites this paper
• Neurocognitive Dimensions of Schizophrenia: An Update

  2021cites this paper
• Therapeutic Targeting of α7 Nicotinic Acetylcholine Receptors

  2021cites this paper
• Small-Molecule Ligands that Bind the RET Receptor Activate Neuroprotective Signals Independent of but Modulated by Coreceptor GFRα1

  2020cites this paper
• The operational model of allosteric modulation of pharmacological agonism

  2020cites this paper
• In silico modeling of the α7 nicotinic acetylcholine receptor: new pharmacological challenges associated with multiple modes of signaling.

  2020cites this paper
• Identification of monellin as the first naturally derived proteinaceous allosteric agonist of metabotropic glutamate receptor 5

  2020cites this paper
• Exploring the Activation Mechanism of the mGlu5 Transmembrane Domain

  2020cites this paper
• Detailed In Vitro Pharmacological Characterization of Clinically Tested Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5

  2020cites this paper
• Structural and Biophysical Mechanisms of Class C G Protein-Coupled Receptor Function.

  2020cites this paper
• In Vitro to in Vivo Translation of Allosteric Modulator Concentration-Effect Relationships: Implications for Drug Discovery.

  2019cites this paper
• Imaging metabotropic glutamate receptor system: Application of positron emission tomography technology in drug development

  2019cites this paper
• Design, synthesis and biological evaluation of indane derived GPR40 agoPAMs.

  2019cites this paper
• Identification of novel allosteric modulators of mGlu5 acting at site distinct from MPEP binding.

  2019cites this paper
• mGlu5 Positive Allosteric Modulators Facilitate Long-Term Potentiation via Disinhibition Mediated by mGlu5-Endocannabinoid Signaling

  2019cites this paper
• Identification of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Acting at Site Distinct from 2-Methyl-6-(phenylethynyl)-pyridine Binding

  2019cites this paper
• Allosteric Modulators of Potential Targets Related to Alzheimer's Disease: a Review

  2019cites this paper
• Positive allosteric modulation of metabotropic glutamate receptor 5 modulates Akt and GSK3β signaling in vivo

  2019cites this paper
• Structural insights into the activation of metabotropic glutamate receptors

  2019cites this paper
• Metabotropic glutamate receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

  2019cites this paper
• Differential Pharmacology and Binding of mGlu2 Receptor Allosteric Modulators

  2018cites this paper
• PF-06827443 Displays Robust Allosteric Agonist and Positive Allosteric Modulator Activity in High Receptor Reserve and Native Systems.

  2018cites this paper
• M1-positive allosteric modulators lacking agonist activity provide the optimal profile for enhancing cognition

  2018cites this paper
• “Selective” Class C G Protein-Coupled Receptor Modulators Are Neutral or Biased mGlu5 Allosteric Ligands

  2018cites this paper
• Biased agonism and allosteric modulation of metabotropic glutamate receptor 5.

  2018cites this paper
• Activated CaMKIIα Binds to the mGlu5 Metabotropic Glutamate Receptor and Modulates Calcium Mobilization

  2018cites this paper
• Intracellular Binding Site for a Positive Allosteric Modulator of the Dopamine D1 Receptor

  2018cites this paper
• Structure-Activity Relationship of Novel and Selective Biaryl-Chroman GPR40 AgoPAMs.

  2018cites this paper
• Physiological activation of mGlu5 receptors supports the ion channel function of NMDA receptors in hippocampal LTD induction in vivo

  2018cites this paper
• GPR40 reduces food intake and body weight through GLP-1.

  2017cites this paper
• Discovery of N-(5-Fluoropyridin-2-yl)-6-methyl-4-(pyrimidin-5-yloxy)picolinamide (VU0424238): A Novel Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 5 Selected for Clinical Evaluation

  2017cites this paper
• Identification and Characterization of the First Selective Y4 Receptor Positive Allosteric Modulator.

  2017cites this paper
• Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery

  2017cites this paper
• Targeting metabotropic glutamate receptors for novel treatments of schizophrenia

  2017cites this paper
• Role of mGlu5 Receptors and Inhibitory Neurotransmission in M1 Dependent Muscarinic LTD in the Prefrontal Cortex: Implications in Schizophrenia.

  2017cites this paper
• Design and Synthesis of Novel, Selective GPR40 AgoPAMs.

  2017cites this paper
• mGlu5 positive allosteric modulation normalizes synaptic plasticity defects and motor phenotypes in a mouse model of Rett syndrome.

  2016influential citation
• VU0477573: Partial Negative Allosteric Modulator of the Subtype 5 Metabotropic Glutamate Receptor with In Vivo Efficacy

  2016cites this paper
• Metabotropic glutamate receptor subtype 5: molecular pharmacology, allosteric modulation and stimulus bias

  2016influential citation
• Leveraging allostery to improve G protein-coupled receptor (GPCR)-directed therapeutics: cannabinoid receptor 1 as discovery target

  2016cites this paper
• Inositol Phosphate Accumulation in Vivo Provides a Measure of Muscarinic M1 Receptor Activation.

  2016cites this paper
• Evidence for Classical Cholinergic Toxicity Associated with Selective Activation of M1 Muscarinic Receptors

  2016cites this paper
• Overview of Critical Parameters for the Design and Execution of a High‐Throughput Screen for Allosteric Ligands

  2016cites this paper
• N-Alkylpyrido[1',2':1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents.

  2016cites this paper
• The role of group I metabotropic glutamate receptors in absence epilepsy

  2016cites this paper
• Enantioselective Synthesis of a Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 5 (mGluR5) Receptor via Dynamic Kinetic Resolution of α-Amino Ketones

  2016cites this paper
• Application of Parallel Multiparametric Cell-Based FLIPR Detection Assays for the Identification of Modulators of the Muscarinic Acetylcholine Receptor 4 (M4)

  2015cites this paper
• Biased mGlu5-Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu5 Modulation of NMDAR Currents.

  2015cites this paper
• Design of 4-Oxo-1-aryl-1,4-dihydroquinoline-3-carboxamides as Selective Negative Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 2.

  2015cites this paper
• Novel Allosteric Modulators of G Protein-coupled Receptors*

  2015cites this paper
• Activation of mGluR5 Attenuates Microglial Activation and Neuronal Apoptosis in Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats

  2015cites this paper
• Small Molecule Therapeutics for Schizophrenia

  2015cites this paper
• Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation

  2015cites this paper
• Quantitative analysis of receptor allosterism and its implication for drug discovery

  2015cites this paper
• Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation s

  2015cites this paper
• Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics.

  2015cites this paper
• Neurobiological Insights from mGlu Receptor Allosteric Modulation

  2015cites this paper
• Relationship between In Vivo Receptor Occupancy and Efficacy of Metabotropic Glutamate Receptor Subtype 5 Allosteric Modulators with Different In Vitro Binding Profiles

  2015influential citation
• Discovery of a Selective and CNS Penetrant Negative Allosteric Modulator of Metabotropic Glutamate Receptor Subtype 3 with Antidepressant and Anxiolytic Activity in Rodents.

  2015cites this paper
• Development of Novel, CNS Penetrant Positive Allosteric Modulators for the Metabotropic Glutamate Receptor Subtype 1 (mGlu1), Based on an N-(3-Chloro-4-(1,3-dioxoisoindolin-2-yl)phenyl)-3-methylfuran-2-carboxamide Scaffold, That Potentiate Wild Type and Mutant mGlu1 Receptors Found in Schizophrenics

  2015cites this paper
• Activation of M1 and M4 muscarinic receptors as potential treatments for Alzheimer’s disease and schizophrenia

  2014cites this paper
• Activation of M 1 and M 4 muscarinic receptors as potential treatments for Alzheimer’s disease and schizophrenia

  2014cites this paper
• Novel mGluR5 Positive Allosteric Modulator Improves Functional Recovery, Attenuates Neurodegeneration, and Alters Microglial Polarization after Experimental Traumatic Brain Injury

  2014cites this paper
• SAR studies on mGlu5 receptor positive allosteric modulators (2003- 2013).

  2014cites this paper
• Activation of the mGlu5 Receptor for the Treatment of Schizophrenia and Cognitive-Deficit-Associated Disorders

  2014cites this paper
• A Duplexed High-Throughput Screen to Identify Allosteric Modulators of the Glucagon-Like Peptide 1 and Glucagon Receptors

  2014cites this paper
• Chemical biology of mGlu4 receptor activation: dogmas, challenges, strategies and opportunities.

  2014cites this paper
• Functional and structural perspectives on allosteric modulation of GPCRs.

  2014cites this paper
• Drugs for allosteric sites on receptors.

  2014cites this paper
• Identification of Selective Agonists and Positive Allosteric Modulators for µ- and δ-Opioid Receptors from a Single High-Throughput Screen

  2014cites this paper
• Identification of specific ligand-receptor interactions that govern binding and cooperativity of diverse modulators to a common metabotropic glutamate receptor 5 allosteric site.

  2014cites this paper
• Positive allosteric modulation of the GHB high-affinity binding site by the GABAA receptor modulator monastrol and the flavonoid catechin.

  2014cites this paper
• Tetrahydronaphthyridine and Dihydronaphthyridinone Ethers As Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 5 (mGlu5)

  2014cites this paper
• Discovery of VU0431316: a negative allosteric modulator of mGlu5 with activity in a mouse model of anxiety.

  2014cites this paper
• Opportunities and challenges in the discovery of allosteric modulators of GPCRs for treating CNS disorders

  2014cites this paper
• A unique industrial-academic collaboration towards the next generation of schizophrenia therapeutics.

  2014cites this paper
• Advancing Quantitative Structure Activity Relationship Strategies in Ligand-based Computer-aided Drug Design

  2014cites this paper
• CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model

  2014cites this paper
• Title: N -aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in pre-clinical models of NMDA hypofunction and cognitive enhancement

  2013influential citation
• N-Aryl Piperazine Metabotropic Glutamate Receptor 5 Positive Allosteric Modulators Possess Efficacy in Preclinical Models of NMDA Hypofunction and Cognitive Enhancement

  2013cites this paper